Interiors & More IPO vs Zenith Drugs IPO

Comparison between Interiors & More IPO and Zenith Drugs IPO.

IPO Details

Interiors & More IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.

	Interiors & More IPO	Zenith Drugs IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Bookbuilding	Bookbuilding
Listing At	NSE SME	NSE SME
Lead Managers	Gretex Corporate Services Ltd.	Gretex Corporate Services Ltd.
Registrar	Bigshare Services Pvt.Ltd.	Bigshare Services Pvt.Ltd.
Market Maker	Gretex Share Broking Pvt.Ltd.	Gretex Share Broking Pvt.Ltd.
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Interiors & More IPO is up to ₹39.89 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Interiors & More IPO is ₹227.00 per share and of Zenith Drugs IPO is ₹79.00 per share.

	Interiors & More IPO	Zenith Drugs IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹216.00 per share	₹75.00 per share
Issue Price (Upper)	₹227.00 per share	₹79.00 per share
Issue Price (Final)	₹227.00 per share	₹79.00 per share
Discount (Retail)	₹0.00 per share	₹0.00 per share
Discount (Employee)
Market Lot Size	600 shares	1600 shares
Fresh Issue Size	17,57,400 shares	42,96,000 shares
Fresh Issue Size (Amount)	up to ₹39.89 Cr	up to ₹33.94 Cr
OFS Issue Size	0 shares	0 shares
OFS Issue Size (Amount)	up to ₹0.00 Cr	up to ₹0.00 Cr
Issue Size Total	17,57,400 shares	42,96,000 shares
Issue Size Total (Amount)	up to ₹39.89 Cr	up to ₹33.94 Cr

IPO Timetable

Interiors & More IPO opens on Feb 15, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Interiors & More IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.

	Interiors & More IPO	Zenith Drugs IPO
Anchor Bid Date	Feb 14, 2024	Feb 16, 2024
Issue Open	Feb 15, 2024	Feb 19, 2024
Issue Close	Feb 20, 2024	Feb 22, 2024
Basis Of Allotment (Tentative)	Feb 21, 2024	Feb 23, 2024
Initiation of Refunds (Tentative)	Feb 22, 2024	Feb 26, 2024
Credit of Share (Tentative)	Feb 22, 2024	Feb 26, 2024
Listing date (Tentative)	Feb 23, 2024	Feb 27, 2024
Anchor Lockin End date 1	Mar 22, 2024	Mar 24, 2024
Anchor Lockin End date 2	May 21, 2024	May 23, 2024

Financials & KPIs

Interiors & More IPO P/E ratio is 19.7, as compared to Zenith Drugs IPO P/E ratio of 18.4.

Interiors & More IPO

Zenith Drugs IPO

Financials

Interiors and More Limited Financial Information (Restated)

Interiors and More Limited's revenue increased by 153.09% and profit after tax (PAT) rose by 467.64% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	3,722.59	3,094.63	1,952.13	1,478.30
Total Income	1,853.78	2,527.17	998.53	663.10
Profit After Tax	354.57	592.84	104.44	43.33
Net Worth	1,349.78	995.21	405.07	300.63
Reserves and Surplus	835.28	823.71	233.57	129.13
Total Borrowing	1,645.86	1,439.77	1,297.33	904.02
Amount in ₹ Lakhs

Zenith Drugs Limited Financial Information (Restated Consolidated)

Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	30 Sep 2023	31 Mar 2023	31 Mar 2022
Assets	11,249.04	9,793.83	6,858.47
Total Income	6,948.43	11,569.65	9,266.63
Profit After Tax	539.38	515.29	312.86
Net Worth	2,264.96	1,724.42	1,209.09
Reserves and Surplus	1,064.96	1,684.42	1,169.09
Total Borrowing	2,902.81	2,605.03	1,880.86
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

95.08

100.00

Promoter Shareholding (Post-Issue)

69.93

69.98

P/E Ratio

19.7

18.4

Market Cap

₹158.80 Cr.

₹135.48 Cr.

ROE

84.68%

35.13%

ROCE

75.58%

37.29%

Debt/Equity

1.45

1.51

EPS

₹11.52

₹4.29

RoNW

59.57%

29.88%

Shares Offered

In the Interiors & More IPO Retail Individual Investors (RII) are offered 6,15,600 shares while in Zenith Drugs IPO retail investors are offered 6,15,600 shares. Qualified Institutional Buyers (QIB) are offered 3,51,600 shares in Interiors & More IPO and 8,59,200 shares in Zenith Drugs IPO.

	Interiors & More IPO	Zenith Drugs IPO
Anchor Investor Reserveration	5,26,200 shares	12,88,000 shares
Market Maker Reserveration	93,000 shares	8,52,800 shares
QIB	3,51,600 shares	8,59,200 shares
NII	2,64,000 shares	6,44,800 shares
RII	6,15,600 shares	15,04,000 shares
Employee
Others
Total	17,57,400 shares	42,96,000 shares

Bids Received (Subscription)

Interiors & More IPO subscribed 11.22x in total, whereas Zenith Drugs IPO subscribed 179.18x.

	Interiors & More IPO	Zenith Drugs IPO
QIB (times)	3.54x	106.72x
NII (times)	30.32x	368.77x
Big NII (times)
Small NII (times)
RII (times)	7.41x	139.28x
Employee (times)
Other (times)
Total (times)	11.22x	179.18x

Compare with others

Interiors & More IPO	Zenith Drugs IPO
Sadhav Shipping IPO	M.V.K.Agro Food Product IPO
Deem Roll Tech IPO	Owais Metal IPO
Zenith Drugs IPO	Purv Flexipack IPO
Esconet Technologies IPO	Sadhav Shipping IPO
Trust Fintech IPO	Deem Roll Tech IPO
Atmastco IPO	Esconet Technologies IPO
Thaai Casting IPO	Trust Fintech IPO
Kalahridhaan Trendz IPO	Interiors & More IPO
Polysil Irrigation Systems IPO	Atmastco IPO
Rudra Gas Enterprise IPO	Thaai Casting IPO